Multiple Manufacturers



Multiple Manufacturers

Retacrit HCPCS:


HCPCS Code Descriptor:

Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units


Q Code

Retacrit NDCs:

00069-1308-10, 59353-0010-10, 00069-1309-04, 59353-0120-10, 59353-0220-10, 00069-1311-10, 00069-1318-10, 59353-0002-01, 59353-0003-01, 59353-0004-01, 59353-0010-01, 59353-0002-10, 00069-1305-10, 59353-0120-01, 59353-0220-01, 00069-1306-10, 59353-0003-10, 59353-0004-10, 00069-1307-10

Primary Type:

Oncology Biosimilar Colony Stimulating Factor

Generic/Specialty Status:


Package Type:


Route of Administration:


Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00069-1308-10, 59353-0010-10, 00069-1309-04, 59353-0120-10, 59353-0220-10, 00069-1311-10, 00069-1318-10, 59353-0002-10, 00069-1305-10, 00069-1306-10, 59353-0003-10, 59353-0004-10, 00069-1307-10

About Retacrit:

RETACRIT is a medication manufactured by multiple manufacturers and aligned to the Q Code: Q5105. RETACRIT is administered via the subcutaneous route of administration.

Retacrit (epoetin) is an artificial protein that aids the production of red blood cells in the body. This medication is used to help with the side effects of certain medications, blood disorders, and kidney disorders. Retacrit is produced by Pfizer and Vifor and is biosimilar to the medications Epogen (J0885) and Procrit (J0885). This medication has two Q Codes: Q5105 for esrd use and Q5106 for non-esrd use. Both these Q codes became effective in January 2020 and still are aligned to the medication. Patient assistance programs can be found through Pfizer Oncology Together and Pfizer RxPathways.


Q5105 Added Date:

July 1, 2018

Q5105 Effective Date:

January 1, 2020

Q5105 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Retacrit billing and coding information.
Retacrit patient assistance information can be found through Pfizer Rx Pathways at the URL:
RETACRIT prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for RETACRIT. Please check back in a few weeks.